Masafumi Iida

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication”.

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication

Journal of Clinical Investigation(2022)10.1172/jci155148

N/A

2.9DataRank · unranked

119 citations

Paul L. Chariou, Sofia R. Gameiro, Haiyan Qin, Masafumi Iida, Kristen Fousek +7 more

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.008

N/A

0.483DataRank · unranked

24 citations

Lucas A. Horn, Haiyan Qin, Madeline Dahut, Masafumi Iida, Dan Yacubovich +5 more

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011378

N/A

0DataRank · unranked

7 citations

Maria Gracia-Hernandez, Loc Le, Masafumi Iida, James L. Gulley, Renee N. Donahue +4 more